Feedback / Questions
Igalmi (dexmedetomedine sublingual) - BioXcel
https://www.globenewswire.com/news-release/2025/11/12/3186085/0/en/BioXcel-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Update-on-Late-Stage-Clinical-Programs-for-Agitation-in-Bipolar-Schizophrenia-and-Alzheimer-s-Disease.html
Nov 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next